Home/Filings/4/0001127602-25-010053
4//SEC Filing

Bradway Robert A 4

Accession 0001127602-25-010053

CIK 0000318154other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:15 PM ET

Size

6.3 KB

Accession

0001127602-25-010053

Insider Transaction Report

Form 4
Period: 2025-03-17
Bradway Robert A
Executive V.P. and CFO
Transactions
  • Tax Payment

    Common Stock

    2025-03-17$313.71/sh12,853$4,032,115587,565 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    90,000
  • Common Stock

    (indirect: By Spousal GRAT)
    90,000
Footnotes (1)
  • [F1]These shares include 2,782 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001396482

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:15 PM ET
Size
6.3 KB